Login / Signup

Randomised controlled trial on the effect of simethicone bowel preparation on rectal variability during image-guided radiation therapy for prostate cancer (SPoRT study).

Jennifer WardSuki GillKevin ArmstrongTamara FogartyDaren TanAlison ScottAylin YahyaSatvinder Singh DhaliwalAngela JacquesColin Tang
Published in: Journal of medical imaging and radiation oncology (2022)
Simethicone did not decrease the RV or GV overall. However, simethicone appeared to significantly decrease the RV variability from Week three onwards. This suggests that taking simethicone two to three weeks before starting radiation therapy may reduce RV variability, although a larger study is needed to confirm this.
Keyphrases
  • mycobacterium tuberculosis
  • prostate cancer
  • radiation therapy
  • randomized controlled trial
  • study protocol
  • clinical trial
  • squamous cell carcinoma
  • radical prostatectomy
  • radiation induced